[Hospital teaching of oncology].

Abstract:

:Theoretical teaching of oncology was improved, 15 years ago, by individualizing a special university course during medical studies in France. However medical students need also practical exercising by relation with cancer patients. The main goals may be defined and given to students at the beginning of practical course and training in an oncology department. Students have to be guided to improve their attitudes. Some experiences are reviewed and permit to help teachers by giving general principles.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Hoerni B,Vrousos C

subject

Has Abstract

pub_date

1985-01-01 00:00:00

pages

1-5

issue

1

eissn

0007-4551

issn

1769-6917

journal_volume

72

pub_type

杂志文章
  • [Management of side effects of targeted therapies in renal cancer: iatrogenic side effects].

    abstract::Since premedication of patients with an H1 antihistamine is recommended before the start of the intravenous infusion of temsirolimus, temsirolimus is to be used with caution in cases where there is a history of hypersensitivity to this class of antihistamines, or medical contra-indication for treatment with antihistam...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1447

    authors: Massard C,Patard JJ,Hermine O,Ravaud A

    更新日期:2011-01-01 00:00:00

  • [The impact of gynaecological cancers on woman's sexuality and her couple].

    abstract::This article, devoted specifically to gynaecological cancers and their impact on the sexual and marital lives, is a collaboration between the psychologists and onco-gynaecologist within a cancer center. In oncology, gynaecological cancers' treatments involve at the same time anatomical, physiological and functional mo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.02.008

    authors: Vanlerenberghe E,Sedda AL,Ait-Kaci F

    更新日期:2015-05-01 00:00:00

  • [Expectations of patients with ovarian cancer. Results of the European investigation EXPRESSION III in French patients from GINECO group].

    abstract::EXPRESSION III was designed to evaluate the information, needs and expectations of patients with ovarian cancer in different European countries. This abstract focuses on specific results from French OC patients. Two hundred and fifty-seven patients filled a 27-item questionnaire during a medical visit. Median age rang...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2014.09.004

    authors: De Cock L,Kieffer A,Kurtz JE,Joly F,Weber B

    更新日期:2015-03-01 00:00:00

  • [Can we enhance the one-day part in breast conservative surgery?].

    abstract:INTRODUCTION:French national guidelines lead us to increase the part of one-day breast cancer conservative surgery. Our objective was to check if we can enhance our outpatient part and to identify solutions to improve our practices. METHODS:From 01/01/2013 to 31/12/2014, we conducted a monocentric and retrospective re...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.09.010

    authors: Gachon B,Nadeau C,Fritel X

    更新日期:2015-12-01 00:00:00

  • [Pulmonary sarcomatoid carcinoma].

    abstract::Pulmonary sarcomatoid carcinomas are a rare group of tumors accounting for about 1 % of non-small cell lung carcinoma (NSCLC). In 2004, World Health Organization classification united under this name all the carcinomas with sarcomatous or sarcomatous-like component with spindle cell or giant cell appearance. There are...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1619

    authors: Vieira T,Duruisseaux M,Ruppert AM,Cadranel J,Antoine M,Wislez M

    更新日期:2012-10-01 00:00:00

  • Pain burden in desmoid tumor patients: a survey of the French Advocacy Group SOS Desmoid.

    abstract:INTRODUCTION:The French Patient Advocacy Group SOS Desmoid conducted a survey to measure the pain burden of desmoid tumor patients. MATERIAL AND METHODS:We used a structured questionnaire to measure the occurrence and consequences of pain. RESULTS:The pain occurrence was approximately 63%. In one-third of the cases, ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.02.001

    authors: Rigaux P,Lefebvre-Kuntz D,Penel N,“SOS Desmoïde”.

    更新日期:2015-03-01 00:00:00

  • The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients.

    abstract::CYP2D6 enzyme is implicated in the metabolism of drugs and nicotine. Genetic variability within CYP2D6, results in different CYP2D6 phenotypes. Inheritance of polymorphic CYP2D6 metabolizing enzyme is likely to be an important determinant of inter-individual variations in susceptibility to cancer. In this work, we hav...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2008.0583

    authors: Ouerhani S,Marrakchi R,Bouhaha R,Ben Slama MR,Sfaxi M,Ayed M,Chebil M,El Gaaied AB

    更新日期:2008-02-01 00:00:00

  • [Axillary lymphadenectomy prepared by fat aspiration versus functional axillary lymphadenectomy: preliminary results of a randomized prospective study].

    abstract::The objective of this study is to compare morbidity between 2 surgical procedures of axillary clearance: functional lymphadenectomy by classical dissection versus axillary dissection prepared by liposuction (Suzanne's procedure). Two hundred consecutive patients treated for breast cancer were included in a prospective...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Giard S,Laurent JC,Dron AM,Lefebvre D

    更新日期:1997-03-01 00:00:00

  • [The use of deodorants/antiperspirants does not constitute a risk factor for breast cancer].

    abstract::Based on the observation of a high incidence of breast cancer in the upper outer quadrant adjacent to the usual area of application of deodorants and/or antiperspirants, several scientific teams have advanced the hypothesis of a possible link between antiperspirants and breast cancer. The possibility of the involvemen...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0679

    authors: Namer M,Luporsi E,Gligorov J,Lokiec F,Spielmann M

    更新日期:2008-09-01 00:00:00

  • [Thyroid carcinoma on struma ovarii: Diagnosis and treatment].

    abstract::Thyroid carcinoma on struma ovarii (TCSO) is a rare ovarian tumour, derivate from monodermic teratomas. It represents about 0.01% of overall ovarian tumours and 5 to 10% of struma ovarii. The diagnosis is histologic and retrospective after pelvic surgery; radiographic imaging being unspecific. Because of its rarity, t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2017.11.014

    authors: Lebreton C,Al Ghuzlan A,Floquet A,Kind M,Leboulleux S,Godbert Y

    更新日期:2018-03-01 00:00:00

  • [Radiosurgery by linear accelerators in the treatment of 84 arteriovenous malformations].

    abstract::We have treated in 1990 and 1991, 84 arteriovenous malformations (AVMs) by radiosurgery. Irradiation was realized by 5 to 7 arcs with 15 MV X rays circular minibeams of a GE-CGR Saturne 43 Linac diameter, at 100 cm 6 to 20 mm; the Betti arm chair and the Talairach frame. The prescribed peripheral dose containing the n...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Schlienger M,Merienne L,Lefkopoulos D

    更新日期:1995-12-01 00:00:00

  • [The surrogate: Partner in the shared decision-making].

    abstract:UNLABELLED:The legislative process of the surrogate appears to be unclear to health professionals and to patients and next of kin. To better adapt this process to the clinical practice our objective was here to document how the persons designated as surrogate perceived their role and how they described the difficulties...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.03.003

    authors: Sarradon-Eck A,Capodano G,Bureau E,Julian-Reynier C

    更新日期:2016-07-01 00:00:00

  • [Gemtuzumab ozogamicin for treatment of acute myeloid leukemia].

    abstract::Gemtuzumab ozogamicin (GO) is a humanized monoclonal antibody anti-CD33 conjugated with calicheamicin and was indicated for acute myeloid leukemia (AML) patients. It was initially approved in 2000 by FDA thank to promising results from a phase II trial including elderly relapsing AML patients. Numerous studies evaluat...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1886

    authors: Brotelle T,Lemal R,Moluçon-Chabrot C,Bay JO,Delaunay J,Guièze R

    更新日期:2014-02-01 00:00:00

  • Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.

    abstract::Newly synthesized dipyrido [4,3-b] [3,4-f] indole compounds have a structural similarity with the DNA intercalating agents ellipticines (pyrido-carbazoles). The procedure of synthesis of these compounds allows the addition of a lateral chain in position 1 of the nucleus. Comparison is made between different substituti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lidereau R,Chermann JC,Gruest J,Montagnier L,Ducrocq C,Rivalle C,Bisagni E

    更新日期:1980-01-01 00:00:00

  • [Rapamycin and CCI-779].

    abstract::Rapamycin (sirolimus) is a macrolide, related to cyclosporine with immunosuppressive properties and antiproliferative activity in various human tumor cells lines and tumor xenograft models. The cytosolic kinase mTOR which controls the initiation of the translation of messenger RNA is the main known target of rapamycin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Alexandre J,Raymond E,Armand JP

    更新日期:1999-10-01 00:00:00

  • [Demonstration of fetal-type thymidine kinase in cancer of the breast].

    abstract::Seventy five human breast cancers were examined in order to search for the presence of thymidine kinase of the fetal-type (TK-F). The presence of TK-F was evidenced in all tumors. Its activity varied from one to another tumor, but it was evident that the increased TK activity observed in mammary cancers could exclusiv...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Javre JL,Hannouche N,Samperez S,Jouan P

    更新日期:1986-01-01 00:00:00

  • [2 malignant cell lines derived from strain L6 of rat myogenic cells].

    abstract::A nonfusing variant M4 of the L6 line of rat myoblasts was isolated. This subline was tumorigenic when inoculated into suckling rats. Comparative studies of cells growth in vitro, serum requirement, cell adhesiveness and capacity to form colonies in soft agar confirmed that M4 cells had undergone neoplastic transforma...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hillion J,Leibovitch MP,Leibovitch SA,Harel J

    更新日期:1982-01-01 00:00:00

  • [Attachment and caregivers' life course facing cancer].

    abstract:INTRODUCTION:Since the last cancer plan 2014-2019, the assessment of the impact of the disease on caregivers became essential. The quality of caregiving represents an important part of the patient's quality of life. The main objective was to describe the evolution of caregiver's attachment style during the first three ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.08.011

    authors: Bonnet M,Vadam F,Belot RA,Quibel C,Pozet A,Nerich V

    更新日期:2020-11-01 00:00:00

  • [Cell cycle and molecular targets: CDK inhibition].

    abstract::Protein phosphorylation is a fundamental post-translational modification. It regulates a large number of critical cellular processes (differentiation, division, proliferation, apoptosis). Cell division is a process including a series of phases by which a parent cell divides into two daughter cells. The cells enter the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1383

    authors: Carassou P,Meijer L,Le Moulec S,Aoun J,Bengrine-Lefèvre L

    更新日期:2012-02-01 00:00:00

  • [Biology of small-cell bronchogenic carcinoma: recent advances].

    abstract::In the last ten years considerable progress has been made in small-cell lung carcinoma (SCLC) biology, along with the technical progress made in molecular biology. This progress now allows us to propose a model for the genesis and the development of this type of tumor. Tobacco, the principal causal factor plays a dual...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Levy R,Andrieu JM,Even P

    更新日期:1992-01-01 00:00:00

  • [Cell cycle regulation after exposure to ionizing radiation].

    abstract::When cells are exposed to ionizing radiation, they initiate a complex response that includes the arrest of cell cycle progression in G1 and G2, apoptosis and DNA repair. DNA is an important subcellular target of ionizing radiation, but oxydative damage to plasma membrane lipids initiates signal transduction pathways t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Teyssier F,Bay JO,Dionet C,Verrelle P

    更新日期:1999-04-01 00:00:00

  • [Imatinib in the treatment of chronic myeloid leukemia in Morocco].

    abstract:INTRODUCTION:The treatment of chronic myeloid leukemia (CML) has been revolutionized by the advent of tyrosine kinase inhibitors. The results of the IRIS trial demonstrated the efficacy and long-term safety profile of Imatinib. The objective of our work is to report the results at 15 years of treatment of CML in chroni...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.013

    authors: Dakkoune M,Qachouh M,Zoukal S,Hassoune S,Khoubila N,Cherkaoui S,Lamchahab M,Rachid M,Madani A,Quessar A

    更新日期:2020-09-01 00:00:00

  • [Malignant cardiac tumors].

    abstract::Cardiac neoplasms are a rare occurrence in clinical practice. The various frequencies of primary and secondary malignant tumors vary from report to report, approximately 1% in most autopsy series and 4% in cancer patient's autopsies. Cardiac malignancies account for less 1% of cardiac surgery and about for 0.1% of car...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Debourdeau P,Gligorov J,Teixeira L,Aletti M,Zammit C

    更新日期:2004-11-01 00:00:00

  • [Recognition of occupational cancers: review of existing methods and perspectives].

    abstract::Occupational risk factors represent a significant part of cancer causes and are involved in all type of cancers. Nonetheless, the frequency of these cancers is largely under-estimated. Parallel to the epidemiological approach (collective), the concept of occupational cancer is often linked (at the individual level) to...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vandentorren S,Salmi LR,Brochard P

    更新日期:2005-09-01 00:00:00

  • [Protontherapy: basis, indications and new technologies].

    abstract::With over 70,000 patients treated worldwide, protontherapy has an evolution on their clinical applications and technological developments. The ballistic advantage of the Bragg peak gives the possibility of getting a high conformation of the dose distribution to the target volume. Protontherapy has accumulated a consid...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1149

    authors: Mazal A,Habrand JL,Delacroix S,Datchary J,Dendale R,Desjardins L,Ferrand R,Malka V,Fourquet A

    更新日期:2010-07-01 00:00:00

  • [Sentinel node biopsy in breast cancer].

    abstract::As compared to conventional axillary dissection, the sentinel node technique is accompanied by reduced morbidity and shorter hospital stay. Based on available data, the use of this technique does not seem to yield higher rates of axillary recurrence. A combination of both radioisotope detection and blue dye increases ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0879

    authors: Hindié E,Groheux D,Espie M,Bourstyn E,Toubert ME,Sarandi F,de Roquancourt A,Giacchetti S,Cuvier C,Cahen-Doidy L,Teyton P,Misset JL,Maylin C,Moretti JL

    更新日期:2009-06-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • [Evolving strategies over time for treatment of breast cancer].

    abstract::The natural history of breast diseases has changed overtime and successive therapeutic strategies have been adapted accordingly. Recently, biological findings on geno- and phenotypic characteristics of tumor cells offer new basis for the development of treatments that target homogenous and various subtypes of breast c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1805

    authors: Roché H

    更新日期:2013-09-01 00:00:00

  • [Cancer and pregnancy: the point of view of the chemotherapy oncologist].

    abstract::Having to start chemotherapy during pregnancy remains a rare event. The decision to proceed this treatment relies on the drugs used, the time of exposure for the foetus and the gestational age at the time of exposure. As a matter of fact, the mutagenicity potential of the chosen medicine has to be known, and consequen...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Pautier P,Lhomme C,Morice P

    更新日期:2002-09-01 00:00:00

  • [Urothelial tumors in children].

    abstract::Urothelial tumors are very rare in children (to date, only about 150 cases have been reported worlwide). Only 20% occur before the age of ten. The aim of this study is to specify the clinicopathologic features of urothelial tumor in young patients, which require a slightly different approach to treatment. On the basis...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.11.018

    authors: Grapin-Dagorno C,Peycelon M,Philippe-Chomette P,Berrebi D,El Ghoneimi A,Orbach D

    更新日期:2017-02-01 00:00:00